131 related articles for article (PubMed ID: 3072996)
1. Modern management of chronic myelogenous leukemia (CML).
Feldman EJ; Arlin ZA
Cancer Invest; 1988; 6(6):737-42. PubMed ID: 3072996
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation for CML.
Mackinnon S; Goldman JM
Baillieres Clin Haematol; 1987 Dec; 1(4):1055-76. PubMed ID: 3332853
[No Abstract] [Full Text] [Related]
3. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
4. Refractory chronic GVHD emerging after splenectomy in a marrow transplant recipient with accelerated phase CML.
Rodrigues CA; Fermino FA; Vasconcelos Y; de Oliveira JS
Bone Marrow Transplant; 2003 Aug; 32(3):333-5. PubMed ID: 12858207
[TBL] [Abstract][Full Text] [Related]
5. Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient.
Varadi G; Ackerstein A; Ben-Neriah S; Nagler A
Bone Marrow Transplant; 1998 Jan; 21(1):93-6. PubMed ID: 9486502
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of chronic myeloid leukemia].
Freund M
Internist (Berl); 1993 Jun; 34(6):542-9. PubMed ID: 8335444
[No Abstract] [Full Text] [Related]
7. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
[No Abstract] [Full Text] [Related]
8. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
Takami A; Chuhjo T; Nakao S
Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
[No Abstract] [Full Text] [Related]
9. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
Fujisawa S; Yano K; Kobayashi M
Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic sarcoma presented as a reactivation of chronic myeloid leukemia after allogenic marrow transplantation.
de Oliveira JS; Chauffaille Mde L; Colleoni GW; Morelli VM; Hauache OM; Alberti VN; Kerbauy J
Sao Paulo Med J; 1998; 116(2):1689-91. PubMed ID: 9778890
[TBL] [Abstract][Full Text] [Related]
11. [Chronic myeloid leukemia: progress and prospects].
Baccarani M; Russo D; Fanin R
Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539
[No Abstract] [Full Text] [Related]
12. [Therapy of chronic myelogenous leukemia in 2004].
Hochhaus A; Berger U; Hehlmann R
Dtsch Med Wochenschr; 2004 Oct; 129(40):2122-7. PubMed ID: 15455305
[TBL] [Abstract][Full Text] [Related]
13. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis.
Schultheis B; Wang L; Clark RE; Melo JV
Leukemia; 2003 Oct; 17(10):2054-5. PubMed ID: 14513059
[No Abstract] [Full Text] [Related]
14. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
[TBL] [Abstract][Full Text] [Related]
15. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of blast crisis of chronic myeloid leukemia].
Kotlarek-Haus S
Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
[TBL] [Abstract][Full Text] [Related]
17. When to Consider Allogeneic Transplantation in CML.
Radich J
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S93-5. PubMed ID: 27521333
[TBL] [Abstract][Full Text] [Related]
18. Isolated CNS relapse of CML after bone marrow transplantation.
Thomas A; Stein CK; Gentile TC; Shah CM
Leuk Res; 2010 Apr; 34(4):e113-4. PubMed ID: 19811825
[No Abstract] [Full Text] [Related]
19. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A
Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872
[TBL] [Abstract][Full Text] [Related]
20. [Chronic leukemia].
Shibata A; Narita M
Gan To Kagaku Ryoho; 1989 May; 16(5):1982-8. PubMed ID: 2658837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
